Fig. 3
From: Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Five-years time to local recurrence (RFS) since tumour free diagnosis for women and men at stages I to III stratified by HER2-status.
Fig. 3 | Scientific Reports
